NFkB p65 (Ab 468) Antibody
CAT:
223-79-263
Size:
0.1 mg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


NFkB p65 (Ab 468) Antibody
Background:
NF-κ -B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-κ -B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-κ -B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-κ -B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-κ -B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-κ -B complex which translocates to the nucleus. NF-κ -B heterodimeric p65-p50 and p65-c-Rel complexes are transcriptional activators. The NF-κ -B p65-p65 complex appears to be involved in invasin-mediated activation of IL-8 expression. The inhibitory effect of I-kappa-B upon NF-κ -B the cytoplasm is exerted primarily through the interaction with p65. p65 shows a weak DNA-binding site which could contribute directly to DNA binding in the NF-κ -B complexNCBI Gene ID:
5970Swiss Prot:
Q04206Accession Number:
NP_001138610.1Host:
RabbitReactivity:
Human, Mouse, RatImmunogen:
NFkB-p65 (Ab-468) antibody was raised against a peptide sequence around aa.466~470 (L-A-S-V-D) derived from Human NFκ B-p65.Clonality:
PolyclonalConjugation:
UnconjugatedType:
Primary AntibodiesField of Research:
Apoptosis, CancerPurification:
Antibodies were purified by affinity-chromatography using epitope-specific peptide.Concentration:
1 mg/mLBuffer:
Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Modification:
NoneShipping Conditions:
Blue IceStorage Conditions:
Store antibody at -20˚ C for up to one year.Calculated Molecular Weight:
65 kDaSpecificity:
This antibody detects endogenous level of total NFκ B-p65 protein.Applications Notes:
Western Blot: 1:500~1:1000, Immunohistochemistry: 1:50~1:100Symbol:
RELANCBI Official Name:
V-rel avian reticuloendotheliosis viral oncogene homolog ANCBI Organism:
Homo sapiensBackground Reference 01:
Buss H, et al. (2004) J Biol ChemSchmitz ML, et al. (2004) BloodOther Product Names:
P65, NFKB3, CDC2, CDC28A, CDKN1, P34CDC2, RELA, TF65, Transcription factor p65, p65Tested Applications:
WB, IHCProtein ID:
223468681Physical Properties:
Liquid